This inventor holds 8 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Medtronic Minimed, Inc.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Hsi Chung Fusselman: Innovator in Medication Infusion Systems
Introduction
Hsi Chung Fusselman is a notable inventor based in Simi Valley, California. He has made significant contributions to the field of medical technology, particularly in the development of systems for medication infusion. With a total of six patents to his name, Fusselman has focused on improving the delivery of essential medications, such as insulin, to patients.
Latest Patents
One of Fusselman's latest patents involves medication infusion components and systems. This invention pertains to systems and components useful for infusing medications, specifically insulin, to diabetic patients. The components are designed to deliver insulin at a site of infusion over a period exceeding four days. The system includes a cannula for subcutaneous insertion into the patient, a fluid conduit for delivering the insulin solution from a medication reservoir, and a depot in operable contact with the fluid conduit. The depot contains selected materials, including a site-loss mitigating agent like heparin, which helps to inhibit inflammation at the infusion site. Notably, the site-loss mitigating agent is not premixed with the insulin but is designed to contact the insulin solution as it flows from the reservoir to the infusion site.
Career Highlights
Fusselman is currently associated with Medtronic Minimed, Inc., a leading company in the medical technology sector. His work has been instrumental in advancing the capabilities of insulin delivery systems, thereby improving the quality of life for diabetic patients.
Collaborations
Throughout his career, Fusselman has collaborated with talented individuals such as Sarnath Chattaraj and Guangping Zhang. These collaborations have contributed to the innovative solutions developed in the field of medication infusion.
Conclusion
Hsi Chung Fusselman is a prominent inventor whose work in medication infusion systems has made a significant impact on diabetes management. His innovative patents and collaborations continue to shape the future of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile